ミオグロビンの世界市場（2022年～2028年）

世界のミオグロビンの市場規模は、予測期間中に4.4%のCAGRで拡大すると予測されています。心血管障害の有病率の上昇は、同市場の拡大の主な要因となっています。

当レポートでは、世界のミオグロビン市場について調査し、市場の概要とともに、タイプ別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 レポートの概要

第2章 市場概要と洞察

第3章 競合情勢

• 主要企業分析
  • Bio-Rad Laboratories, Inc
  • Merck KGaA
  • OriGene Technologies, Inc.
  • Scripps Labs
  • Thermo Fisher Scientific Inc.
• 主要戦略分析
• COVID-19が主要参入企業に与える影響

第4章 市場セグメンテーション

• 世界のミオグロビン市場、タイプ別
  • 人間
  • 動物
• 世界のミオグロビン市場、エンドユーザー別
  • 病院と診療所
  • 研究機関
  • 試験所

第5章 地域分析

• 北米
• 欧州
• アジア太平洋
• その他の地域

第6章 企業プロファイル

• Abbott
• Beckman Coulter, Inc.
• BioMerieux SA
• Boditech Med Inc.
• Calzyme
• F. Hoffmann-La Roche Ltd.
• Labsystems Diagnostics
• Lee BioSolutions
• LSI Medience Corp.
• Randox Laboratories Ltd.
• RESPONSE BIOMEDICALAtum Charge
• Siemens Healthcare GmbH

LIST OF TABLES

• 1. GLOBAL MYOGLOBIN MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
• 2. GLOBAL HUMAN MYOGLOBIN MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 3. GLOBAL ANIMAL MYOGLOBIN MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 4. GLOBAL MYOGLOBIN MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
• 5. GLOBAL HOSPITALS & CLINICS FOR MYOGLOBIN MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 6. GLOBAL RESEARCH INSTITUTE FOR MYOGLOBIN MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 7. GLOBAL LABORATORIES FOR MYOGLOBIN MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
• 8. GLOBAL MYOGLOBIN MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
• 9. NORTH AMERICAN MYOGLOBIN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
• 10. NORTH AMERICAN MYOGLOBIN MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
• 11. NORTH AMERICAN MYOGLOBIN MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
• 12. EUROPEAN MYOGLOBIN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
• 13. EUROPEAN MYOGLOBIN MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
• 14. EUROPEAN MYOGLOBIN MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
• 15. ASIA-PACIFIC MYOGLOBIN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
• 16. ASIA-PACIFIC MYOGLOBIN MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
• 17. ASIA-PACIFIC MYOGLOBIN MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)
• 18. REST OF THE WORLD MYOGLOBIN MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
• 19. REST OF THE WORLD MYOGLOBIN MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
• 20. REST OF THE WORLD MYOGLOBIN MARKET RESEARCH AND ANALYSIS BY END-USER, 2021-2028 ($ MILLION)

LIST OF FIGURES

• 1. IMPACT OF COVID-19 ON GLOBAL MYOGLOBIN MARKET, 2021-2028 ($ MILLION)
• 2. IMPACT OF COVID-19 ON GLOBAL MYOGLOBIN MARKET BY SEGMENT, 2021-2028 ($ MILLION)
• 3. RECOVERY OF GLOBAL MYOGLOBIN MARKET, 2022-2028 (%)
• 4. GLOBAL MYOGLOBIN MARKET SHARE BY TYPE, 2021 VS 2028 (%)
• 5. GLOBAL HUMAN MYOGLOBIN MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
• 6. GLOBAL ANIMAL MYOGLOBIN MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
• 7. GLOBAL MYOGLOBIN MARKET SHARE BY END-USER, 2021 VS 2028 (%)
• 8. GLOBAL HOSPITALS & CLINICS FOR MYOGLOBIN MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
• 9. GLOBAL RESEARCH INSTITUE FOR MYOGLOBIN MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
• 10. GLOBAL LABORATORIES FOR MYOGLOBIN MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
• 11. GLOBAL MYOGLOBIN MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
• 12. US MYOGLOBIN MARKET SIZE, 2021-2028 ($ MILLION)
• 13. CANADA MYOGLOBIN MARKET SIZE, 2021-2028 ($ MILLION)
• 14. UK MYOGLOBIN MARKET SIZE, 2021-2028 ($ MILLION)
• 15. FRANCE MYOGLOBIN MARKET SIZE, 2021-2028 ($ MILLION)
• 16. GERMANY MYOGLOBIN MARKET SIZE, 2021-2028 ($ MILLION)
• 17. ITALY MYOGLOBIN MARKET SIZE, 2021-2028 ($ MILLION)
• 18. SPAIN MYOGLOBIN MARKET SIZE, 2021-2028 ($ MILLION)
• 19. REST OF EUROPE MYOGLOBIN MARKET SIZE, 2021-2028 ($ MILLION)
• 20. INDIA MYOGLOBIN MARKET SIZE, 2021-2028 ($ MILLION)
• 21. CHINA MYOGLOBIN MARKET SIZE, 2021-2028 ($ MILLION)
• 22. JAPAN MYOGLOBIN MARKET SIZE, 2021-2028 ($ MILLION)
• 23. SOUTH KOREA MYOGLOBIN MARKET SIZE, 2021-2028 ($ MILLION)
• 24. REST OF ASIA-PACIFIC MYOGLOBIN MARKET SIZE, 2021-2028 ($ MILLION)
• 25. REST OF THE WORLD MYOGLOBIN MARKET SIZE, 2021-2028 ($ MILLION)

Global Myoglobin Market Size, Share & Trends Analysis Report By Type (Human and Animal), and By End-User (Hospitals & Clinics, Research Institute, and Laboratories) Forecast Period (2022-2028)

The global myoglobin market is anticipated to grow at a substantial CAGR of 4.4% during the forecast period. The rising prevalence of cardiovascular disorders is the primary factor driving the market's expansion. According to the World Health Organization, due to cardiovascular disease (CVDs) 17.9 million people died in 2019, accounting for 32% of all deaths globally. One of the conditions that can occur as a result of cardiovascular disease is myocardial infarction. It has a high rate of mortality and morbidity. In addition, the market is likely to be driven by rising funding for R&D and technical improvements from both public and private entities over the forecast period. Myoglobin levels are measured to diagnose myositis, myocardial infarction, and to treat muscular dystrophy and myopathy. The amount of myoglobin released into the blood upon cellular injury is measured using myoglobin regents.

The global myoglobin market is segmented based on type and end-user. Based on the type, the market is sub-segmented into human and animal. Based on the end-user, the market is sub-segmented into hospitals & clinics, research institute, and laboratories. Among these, the hospital & clinics segment is impacting the market significantly. Myoglobin reagents in hospital laboratories are primarily used to detect high levels of myoglobin in patients who have had heart surgery or other trauma resulting in internal bleeding, which may cause myoglobin to be released from muscle cells.

Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. Asia-Pacific holds a significant share in the market after North America. The factor that is driving the market in the region is the growing awareness, and also due to a high number of cardiac surgeries had impacted the market. Asia-pacific people are increasingly using myoglobin reagents for screening and diagnosis as awareness of its utility as an accurate biomarker of left ventricular wall thickening (LVWT) grows.

The major companies serving the global myoglobin market include Bio-Rad Laboratories, Inc., Merck KGaA, OriGene Technologies, Inc., Scripps Labs, Thermo Fisher Scientific Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in November 2021, Thermo Fisher Scientific Inc., launched new mass spectrometry and chromatography solutions. The new approach streamlines the transition of biotherapeutics from discovery to manufacture by allowing quality control (QC) customers to use the same technology used earlier in a molecule's route to commercialization, enabling the biopharma pipeline to move more quickly.

Research Methodology

The market study of the global myoglobin market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

• Financial reports of companies involved in the market.
• Whitepapers, research papers, and news blogs.
• Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. Global Myoglobin Market Research and Analysis by Type

2. Global Myoglobin Market Research and Analysis by End-User

The Report Covers:

• Comprehensive Research Methodology of the global myoglobin market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the global myoglobin market.
• Insights about market determinants that are stimulating the global myoglobin market.
• Detailed and extensive market segments with the regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Myoglobin Market
• Recovery Scenario of Global Myoglobin Market
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. BY Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
  • 3.1.1. Bio-Rad Laboratories, Inc
    • 3.1.1.1. Overview
    • 3.1.1.2. Financial Analysis
    • 3.1.1.3. SWOT Analysis
    • 3.1.1.4. Recent Developments
  • 3.1.2. Merck KGaA
    • 3.1.2.1. Overview
    • 3.1.2.2. Financial Analysis
    • 3.1.2.3. SWOT Analysis
    • 3.1.2.4. Recent Developments
  • 3.1.3. OriGene Technologies, Inc.
    • 3.1.3.1. Overview
    • 3.1.3.2. Financial Analysis
    • 3.1.3.3. SWOT Analysis
    • 3.1.3.4. Recent Developments
  • 3.1.4. Scripps Labs
    • 3.1.4.1. Overview
    • 3.1.4.2. Financial Analysis
    • 3.1.4.3. SWOT Analysis
    • 3.1.4.4. Recent Developments
  • 3.1.5. Thermo Fisher Scientific Inc.
    • 3.1.5.1. Overview
    • 3.1.5.2. Financial Analysis
    • 3.1.5.3. SWOT Analysis
    • 3.1.5.4. Recent Developments
• 3.2. Key Strategy Analysis
• 3.3. Impact of COVID-19 on Key Players

4. Market Segmentation

• 4.1. Global Myoglobin Market by Type
  • 4.1.1. Human
  • 4.1.2. Animal
• 4.2. Global Myoglobin Market by End-User
  • 4.2.1. Hospitals & Clinics
  • 4.2.2. Research Institute
  • 4.2.3. Laboratories

5. Regional Analysis

• 5.1. North America
  • 5.1.1. US
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World

6. Company Profiles

• 6.1. Abbott
• 6.2. Beckman Coulter, Inc.
• 6.3. BioMerieux SA
• 6.4. Boditech Med Inc.
• 6.5. Calzyme
• 6.6. F. Hoffmann-La Roche Ltd.
• 6.7. Labsystems Diagnostics
• 6.8. Lee BioSolutions
• 6.9. LSI Medience Corp.
• 6.10. Randox Laboratories Ltd.
• 6.11. RESPONSE BIOMEDICALAtum Charge
• 6.12. Siemens Healthcare GmbH